about
A statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study.The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition.Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants.Lifestyle, dietary factors, and antibody levels to oral bacteria in cancer-free participants of a European cohort study.Fruit and vegetable consumption in relation to hepatocellular carcinoma in a multi-centre, European cohort study.Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort.Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC).Vitamin C transporter gene (SLC23A1 and SLC23A2) polymorphisms, plasma vitamin C levels, and gastric cancer risk in the EPIC cohortDietary benzo(a)pyrene and fetal growth: effect modification by vitamin C intake and glutathione S-transferase P1 polymorphism.Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort.Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population.Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study.Dietary fat, fat subtypes and hepatocellular carcinoma in a large European cohort.Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort.Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study.Dairy products and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition.Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study.Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition and Cancer Study.Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations.Dietary flavonoid, lignan and antioxidant capacity and risk of hepatocellular carcinoma in the European prospective investigation into cancer and nutrition study.Dietary benzo(a)pyrene intake during pregnancy and birth weight: associations modified by vitamin C intakes in the Norwegian Mother and Child Cohort Study (MoBa).Maternal dietary intake of dioxins and polychlorinated biphenyls and birth size in the Norwegian Mother and Child Cohort Study (MoBa).Leukocyte telomere length in relation to pancreatic cancer risk: a prospective study.Meat and heme iron intake and esophageal adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition study.Prospective association of liver function biomarkers with development of hepatobiliary cancers.Social inequalities in health among adolescents in a large southern European city.Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk.Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: results from the EPIC-EURGAST study.Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohortPlasma and dietary carotenoids and vitamins A, C and E and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and NutritionReal-world data reveal a diagnostic gap in non-alcoholic fatty liver diseaseRisks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohortsNon-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adultsADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccinationADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modellingAdvance system testing: Vaccine benefit studies using multi-country electronic health data - The example of pertussis vaccinationQuantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE projectADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases
P50
Q30977795-E00332CC-5055-4C66-BCD5-EF3D39D6BCDBQ31022208-94AF6F2B-61BD-4943-973C-B75F4738756BQ34511085-2CC037B4-BAD7-49CF-AF12-A0C8A329D2FFQ34627395-99B831F4-9004-4A15-BAF3-844DB8AFBB18Q34882075-C86F6EAA-6919-4944-993D-7CE51BAA99BDQ35274846-6167EB96-DBBC-427E-AB9C-8CDBA58AD8EEQ35785514-172C696C-A861-447F-83E7-518EA8F81FFFQ37032871-FB3B5F00-5A8E-4392-8A1B-658B07A30AA1Q37300010-35D9BD9B-5122-4EEF-86C2-DF6F2C2F1AB7Q37373458-A45CD2DF-6837-4472-BAB9-67C577D51EAAQ40675361-4E0B1D64-C982-4912-A2C8-756FA22A5B16Q40684396-5A49DA9A-3F4F-42E4-A498-0CE958A527FAQ41518664-FC2A4DE4-E199-4E8E-8BCB-ABF963873EECQ41664327-89A7E0B2-F814-4855-B1F4-EDC8BD7A11C0Q41664411-6E75D153-4D80-42FD-87B2-EFF6BF8311DCQ42230477-B6681A9C-346C-4A28-845D-08C0B8BAFEA5Q42232504-7BC3B118-F4FF-41AA-B9C0-8B308E972C25Q43420832-90F74BB0-20A1-4C09-BABC-40637FD7BDCBQ43745661-5F318F10-12B8-4D3F-8B72-CBF2FE08C9CDQ44054901-68B5CEFC-B5A0-4096-B445-E167955DAD35Q45986634-652F0F31-C682-4307-A430-D9A0636C455EQ46669527-316FD315-1B9B-4B7F-93A1-A9016D3B5826Q47208159-3520242E-A006-4AFF-8878-D1FBA7028899Q47741928-B5228C0A-E464-4AA1-B608-64C04E4FACA2Q50490222-A272BD1F-08CA-47CB-A81A-947726B04CEDQ50724138-F3CEBA9F-E4CC-4EF0-A300-FC1A97BF7091Q51768634-D04A767D-214F-4B57-8411-0BE2B340E3CDQ52875254-D06CCC4D-B450-4749-BFC8-3C84E1C0DEF9Q53061705-5BCCE270-A35E-461A-9D06-13F23D1D11D8Q53237600-D564DAE7-385B-43D5-BA93-2632FDAED999Q57026139-9EDC3433-2A35-42AD-ADA0-2F39BAA8428FQ57026439-5618EB12-EC80-4AEC-B551-F4A3DE64190DQ58787282-1C1FE482-0D21-4001-B933-C529B3EA7AA0Q64108739-A70A0BB7-0587-4ADB-B24F-2A4AA055BAACQ90596788-AE2CBC03-6DBF-4BBF-A5B0-2726D863D352Q91068795-910FF30F-A1B0-4F5C-B1E1-88B692381993Q91068799-3C1F27B3-7ABB-4F1D-973B-D7D761673D13Q91068808-FC9E9DBE-55D4-40B6-9072-ACF4C57BEED8Q91068814-32A4FEF8-C263-4800-8029-F774ED98ECE2Q91068818-36C1DC0E-F860-46C4-A468-7C96DC1B51D8
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Talita Duarte-Salles
@ast
Talita Duarte-Salles
@en
Talita Duarte-Salles
@es
Talita Duarte-Salles
@nl
Talita Duarte-Salles
@sl
type
label
Talita Duarte-Salles
@ast
Talita Duarte-Salles
@en
Talita Duarte-Salles
@es
Talita Duarte-Salles
@nl
Talita Duarte-Salles
@sl
altLabel
Duarte-Salles T
@en
prefLabel
Talita Duarte-Salles
@ast
Talita Duarte-Salles
@en
Talita Duarte-Salles
@es
Talita Duarte-Salles
@nl
Talita Duarte-Salles
@sl
P106
P1153
36767041500
P21
P31
P496
0000-0002-8274-0357